These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22074580)

  • 1. Hypoglycemic agents in the management of type 2 diabetes mellitus.
    Ho J; Leung AK; Rabi D
    Recent Pat Endocr Metab Immune Drug Discov; 2011 Jan; 5(1):66-73. PubMed ID: 22074580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Current and Emerging Glucose-Lowering Drugs on Body Weight in Type 2 Diabetes.
    Lau DC; Teoh H
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S148-54. PubMed ID: 26654858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of promising therapies in diabetes mellitus.
    Akkati S; Sam KG; Tungha G
    J Clin Pharmacol; 2011 Jun; 51(6):796-804. PubMed ID: 20705952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological efficacy of FGF21 analogue, liraglutide and insulin glargine in treatment of type 2 diabetes.
    Ye X; Qi J; Yu D; Wu Y; Zhu S; Li S; Wu Q; Ren G; Li D
    J Diabetes Complications; 2017 Apr; 31(4):726-734. PubMed ID: 28143735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium-glucose cotransporter inhibition: therapeutic potential for the treatment of type 2 diabetes mellitus.
    Raskin P
    Diabetes Metab Res Rev; 2013 Jul; 29(5):347-56. PubMed ID: 23463735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of action of metformin in type 2 diabetes and associated complications: an overview.
    Correia S; Carvalho C; Santos MS; Seiça R; Oliveira CR; Moreira PI
    Mini Rev Med Chem; 2008 Nov; 8(13):1343-54. PubMed ID: 18991752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Insulins, Biosimilars, and Insulin Therapy.
    Danne T; Heinemann L; Bolinder J
    Diabetes Technol Ther; 2017 Feb; 19(S1):S42-S58. PubMed ID: 28192016
    [No Abstract]   [Full Text] [Related]  

  • 10. New concepts in diabetes: how multihormonal regulation can improve glycemic control.
    Blonde L; Baker DE; Davis SN; Ratner RE
    J Manag Care Pharm; 2004 Dec; 10(6 Suppl B):S3-8; quiz S9, S11-2. PubMed ID: 23570175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin therapy in type 2 diabetes.
    Mudaliar S; Edelman SV
    Endocrinol Metab Clin North Am; 2001 Dec; 30(4):935-82. PubMed ID: 11727406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent and emerging therapeutic medications in type 2 diabetes mellitus: incretin-based, Pramlintide, Colesevelam, SGLT2 Inhibitors, Tagatose, Succinobucol.
    Lo MC; Lansang MC
    Am J Ther; 2013; 20(6):638-53. PubMed ID: 20838206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GLP-1 receptor agonists for type 2 diabetes mellitus: recent developments and emerging agents.
    Trujillo JM; Nuffer W
    Pharmacotherapy; 2014 Nov; 34(11):1174-86. PubMed ID: 25382096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigational agents that protect pancreatic islet beta-cells from failure.
    Aston-Mourney K; Proietto J; Andrikopoulos S
    Expert Opin Investig Drugs; 2005 Oct; 14(10):1241-50. PubMed ID: 16185166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of timely basal insulin control in patients with type 2 diabetes.
    Lovre D; Fonseca V
    J Diabetes Complications; 2015 Mar; 29(2):295-301. PubMed ID: 25536866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel and Emerging Insulin Preparations for Type 2 Diabetes.
    Cheung KK; Alexander P
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S160-6. PubMed ID: 26653255
    [No Abstract]   [Full Text] [Related]  

  • 17. Progress in the treatment of type 2 diabetes: new pharmacologic approaches to improve glycemic control.
    Cohen A; Horton ES
    Curr Med Res Opin; 2007 Apr; 23(4):905-17. PubMed ID: 17407648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Diabetes Association--68th Scientific Sessions. Clinical trial results.
    Glah D
    IDrugs; 2008 Aug; 11(8):556-8. PubMed ID: 18683087
    [No Abstract]   [Full Text] [Related]  

  • 19. NMDAR antagonists for the treatment of diabetes mellitus-Current status and future directions.
    Welters A; Klüppel C; Mrugala J; Wörmeyer L; Meissner T; Mayatepek E; Heiss C; Eberhard D; Lammert E
    Diabetes Obes Metab; 2017 Sep; 19 Suppl 1():95-106. PubMed ID: 28880473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial watch: SGLT2 inhibitor shows promise in type 2 diabetes.
    Nat Rev Drug Discov; 2010 Mar; 9(3):182. PubMed ID: 20190779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.